- Module code: BS971
- Module name: Vaccines & Gene Therapy
- Department: School of Life Sciences
- Credit: 10
Content and teaching | Assessment | Availability
Module content and teaching
This module is designed to equip students with the necessary knowledge and skills base to undertake the appraisal, industrial application and exploitation of an idea in the vaccination/gene therapy sector of biosciences. It is an elective module for the MSc in Biotechnology, Bioprocessing and Business Management which when combined with the other electives in the biopharmaceutical area will provide a new industrial focus for students pursuing this Masters programme. The context of this module is that it sits within a programme that seeks to explain the increasing importance of integrating knowledge transfer, key regulatory and ethical issues, protection of ideas generation and funding to commercialisation.
Principal learning outcomes
Subject knowledge and understanding: By the end of the module the student should have a broad knowledge and understanding of the fundamental principles of vaccines, vaccination and gene therapy. A detailed understanding of vaccine development manufacture and use; ability to assess the potential for application, optimisation and commercialisation of biological processes relating to vaccines and gene therapy. Recognise and analyse the problems associated with the development and use of biological systems in relation to vaccines and gene therapy leading to a commercial process. Recognise the underlying principles associated with the transition of processes from the laboratory through manufacture to end use. The role of a multi-disciplinary approach to solving problems with vaccine development/implementation. Have a thorough understanding of the immune system, viral/cancer diagnosis and the role(s) of cancer vaccines and gene therapy. Be aware of issues involved in the exploitation of vaccines and gene therapy. Recognise the importance of education, multidisciplinary interaction and research for the future development of the speciality. Demonstrate an understanding of ethical issues pertinent to vaccines and gene therapy.
Timetabled teaching activities
Lectures per week 10 x 1 hour; Seminar sessions 8 x 1 hour.
|Assessment group||Assessment name||Percentage|
|10 CATS (Module code: BS971-10)|
|A1 (Assessed work only)||Assessed Course Work||40%|
|Assessed Course Work||60%|
This module is available on the following courses:
- Postgraduate Medical Biotechnology and Business Management (J7N2) - Year 1